Dementia death rates prediction

Abstract

Background Prevalence of dementia illness, causing certain morbidity and mortality globally, places burden on global public health. This study primary goal was to assess future risks of dying from severe dementia, given specific return period, within selected group of regions or nations. Methods Traditional statistical approaches do not have benefits of effectively handling large regional dimensionality, along with nonlinear cross-correlations between various regional observations. In order to produce reliable long-term projections of excessive dementia death rate risks, this study advocates novel bio-system reliability technique, that being particularly suited for multi-regional environmental, biological, and health systems. Data Raw clinical data has been used as an input to the suggested population-based, bio-statistical technique using data from medical surveys and several centers. Results Novel spatiotemporal health system reliability methodology has been developed and applied to dementia death rates raw clinical data. Suggested methodology shown to be capable of dealing efficiently with spatiotemporal clinical observations of multi-regional nature. Accurate disease risks multi-regional spatiotemporal prediction being done, relevant confidence intervals have been presented as well. Conclusions Based on available clinical survey dataset, the proposed approach may be applied in a variety of clinical public health applications. Confidence bands, given for predicted dementia-associated death rate levels with return periods of interest, have been reasonably narrow, indicating practical values of advocated prognostics.

Gaidai reliability method for long-term coronavirus modelling

“…25, these studies however did not address fully dynamic space-time dynamic biosystem as this study does. [66][67][68][69][70][71][72] Note that while this study aims at reducing risk of future epidemic outbreaks by predicting them, it is solely focused on daily registered patient numbers and not on symptoms themselves. For long-lasting COVID-19 symptoms, the so-called "long COVID", and its risk factors and whether it is possible to predict a protracted course early in the disease, see Ref.…”

First-Principles Approach for Assessing the Detection of Alzheimer’s Biomarkers Using Titanium Carbide MXenes

“…According to the World Health Organization (WHO), more than 55 million people are suffering from dementia worldwide, with around 10 million new cases added in 2022. Dementia is regarded by WHO as the seventh leading cause of death and predominant cause of disability among the older people, 65 years or older, globally . This disease affects memory, thinking, and the ability to perform daily activities.…”

“…This disease affects memory, thinking, and the ability to perform daily activities. It may affect older people as a result of developing other diseases (e.g., hypertension, diabetes, obesity, smoking, alcoholism, and depression). , The Global Dementia Observatory (GDO), which is responsible for collecting data and an accountability mechanism for the global action plan on the public response to dementia from 2017 to 2025, provides support of around US$ 1.3 trillion in 2019 to cover the cost of care …”

“…Dementia is regarded by WHO as the seventh leading cause of death and predominant cause of disability among the older people, 65 years or older, globally. 1 This disease affects memory, thinking, and the ability to perform daily activities. It may affect older people as a result of developing other diseases (e.g., hypertension, diabetes, obesity, smoking, alcoholism, and depression).…”

Evaluation of knowledge and attitudes regarding Alzheimer’s disease and related dementia among medical students in Palestine: A cross-sectional study

“…Dementia is an acquired disorder that causes cognitive abilities to decline over time, affecting learning and memory, language, executive function, complex attention, perceptual-motor skills, and social cognition [1,2]. Dementia, a major global health concern, currently affects over 55 million people worldwide [3], with low-and middle-income countries accounting for more than 60% of cases. Each year, nearly 10 million new cases are documented [4].…”